Johnson & Johnson (JNJ) is a household name thanks to products like Band Aid, Tylenol, and Benadryl. The company also has prescription pharmaceuticals and medical device divisions as well. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
The fundamentals toward JNJ are incredibly strong, especially for a company that has been around for over 130 years.
The return on equity is 56.9%, the profit margin is 31.7% and the operating margin is 25.1%. The earnings per share have been growing at a rate of 5% over the past three years and analysts expect them to grow at a rate of 7.8% over the next five years.
JNJ has formed a trend channel on its weekly chart that goes all the way back to the fourth quarter of 2015. The stock did drop below the trend channel and below its 52-week moving average yesterday, but it did recover some of the losses and closed back up at the lower rail of the channel and just below the moving average.
The sentiment toward JNJ has become decidedly more bearish in recent weeks and the SentimenTrader optix reading hit an extreme low last Friday. In fact the sentiment was at its lowest level since August ’15.
Suggested strategy: Buy JNJ with a maximum entry price of $135.00. I would set a target of at least $170 in the next six months, for a 30% potential return from current prices. I would also set a stop-loss at $115.
— Rick PendergraftThis Stock Could Be Like Buying Amazon in 1997 [sponsor]
A little-known Canadian company just went public and it's already made people rich, including one lucky insider -- a ski-bum with strong coding skills -- who made $782 million with his stake in the company. But that's not why investors are buying shares hand over fist right now. The real reason is that they think this stock will make them rich, too. Click here to learn how you can profit.